Today: 29 June 2026
Browse Category

NASDAQ:LQDA 2 January 2026 - 11 January 2026

Liquidia stock jumps after $148.3 million YUTREPIA sales update — what LQDA investors watch next week

Liquidia stock jumps after $148.3 million YUTREPIA sales update — what LQDA investors watch next week

Liquidia shares rose 12.9% to $35.86 Friday after the company reported preliminary 2025 YUTREPIA sales of $148.3 million, with $90.1 million in Q4. The company ended 2025 with $190.7 million in cash and over $30 million in positive Q4 cash flow. CEO Roger Jeffs will present at the J.P. Morgan Healthcare Conference on Jan. 14. Audited results are expected in February.
Liquidia stock drops 8% today as put-option hedging spikes — what’s next for LQDANEW YORK, Jan 2, 2026, 14:24 ET — Regular session

Liquidia stock drops 8% today as put-option hedging spikes — what’s next for LQDANEW YORK, Jan 2, 2026, 14:24 ET — Regular session

Liquidia shares fell about 8% Friday, closing at $31.70 after swinging between $30.76 and $34.97 on heavy volume. Options trading showed a surge in put buying, with 15,696 contracts traded, 56% above normal. The drop outpaced biotech peers as investors watched for updates on the company’s patent dispute over Yutrepia and its next earnings report, expected March 18.

Stock Market Today

  • DAIHEN (TSE:6622) Shows Strong Returns But Trades at High Valuation
    June 29, 2026, 2:07 AM EDT. DAIHEN (TSE:6622) has posted significant gains with a 30-day return of 15.52% and a year-to-date return of 71.76%, driving total shareholder returns up 192.25% over one year. The company, involved in transformers, welding equipment, industrial robots, and power solutions, ended trading at ¥18,310 with a price-to-earnings (P/E) ratio of 30.6x, which is notably higher than its industry average of 14.6x and peers at 20x. This premium reflects strong earnings growth of 18% last year and forecasted annual earnings growth near 18%. However, the stock may be overvalued as per the SWS discounted cash flow (DCF) model, suggesting limited downside cushion if growth slows, raising caution for investors given the high P/E and elevated recent total returns.

Latest articles

Trump-era loan caps could open door for private lenders in grad school market

Trump-era loan caps could open door for private lenders in grad school market

29 June 2026
July 1 federal loan caps slash Grad PLUS access, forcing many graduate and professional students to seek private loans; Sallie Mae projects up to 70% origination growth over several years, while SoFi reports record student-loan volume—investors now face a real-time test of how much demand shifts to private lenders as federal limits hit.
IREN Limited (NASDAQ:IREN) slides as Warriors badge faces AI revenue test

IREN Limited (NASDAQ:IREN) slides as Warriors badge faces AI revenue test

29 June 2026
IREN Limited (NASDAQ:IREN) plunged 21.3% to $47.21 over five straight down days despite announcing a record $50M+ annual Warriors jersey deal, as investors focused on the company’s not fully contracted $4.4B target ARR and high short interest at 19.74% of float, with Friday’s close near the lowest analyst target.
Go toTop